The Scientist - Home

A massive research program investigating causal links between the gut microbiome and autism sparked fierce pushback from scientific critics and advocacy groups.

Let’s take a moment to celebrate the medium that found a home in our drawers and hearts for 40 years. 

Hospitals have used genomics to explain outbreaks after they happen. Falling sequencing costs now make it possible to catch outbreaks before they go beyond two patients.

Genetically modified yeast mixed with gelatin creates a durable biomaterial that could help build habitats under harsh Martian conditions.

Diabetic neuropathy is a painful complication of diabetes, but selective monoclonal antibodies against a key inflammatory molecule could lead to a treatment.

We had no seed money, no template, and a question no one had asked in Brazil. Here's how we pulled it off.

This postdoctoral researcher explores plant-associated microbiomes and hopes to leverage these interactions to grow resilient crops and promote global food security.

Researchers testing out CRISPR systems found that their ability to disrupt gene expression was artificially enhanced by an issue with a measurement technique.  

More than a decade of work led to a dual-targeting antibody mimic of a blood clotting protein to treat hemophilia A. Three scientists received a Lasker Award for their efforts.

US-based researchers are seeking academic asylum in Germany following the Trump administration’s funding cuts—a loss to American science.

Regulators are steering drug testing away from animals, and the systems stepping in each capture only a slice of a living body.

This postdoctoral researcher explores how genetic variation and social determinants influence personalized health outcomes.